Key facts
- It has raised $61.3M; the latest was Later Stage VC in Feb 2025.
- Notable investors include Legend Star, Sinovation Ventures, Eastern Bell Venture Capital, Qingdao Haier Venture Capital, Xingtuo Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Tianjin Aiden Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Tianjin Aiden Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tianjin Aiden Technology
Developer of a medical data analytic platform. The company develops its core technology around nosology to better classify diseases through data mining, providing medical institutions with better efficiency and data-driven monitoring tools, while also supporting features such as modular customization, scalable deployment, and compatibility with industrial standards, enabling manufacturing enterprises and engineering markets to enhance production efficiency, improve reliability of equipment, ensure quality assurance, and expand the scope of advanced technological applications in industrial environments.
- Sector
- Healthcare
- HQ
- Tianjin, China
- Founded
- 2016
- Employees
- 223
- Website
- yadingdata.com/
- Ownership
- Privately Held (backing)
Tianjin Aiden Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tianjin Aiden Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tianjin Aiden Technology in its N-PORT filings yet. We sweep new filings monthly.